Johnson & JohnsonSEC Filings
|
|
All SEC filings by Johnson & Johnson (JNJ) — annual and quarterly reports, current reports, registrations, proxies and ownership forms, updated in real time.
Financials
| 10-Q | Quarterly report | View Diff | Jul 23, 2026 | |
| 10-Q | Quarterly report | View Diff | Apr 22, 2026 | |
| ARS | Annual report to shareholders | Mar 11, 2026 | ||
| 10-K | Annual report | View Diff | Feb 11, 2026 | |
| 10-Q | Quarterly report | View Diff | Oct 22, 2025 | |
| 10-Q | Quarterly report | View Diff | Jul 24, 2025 | |
| 10-Q | Quarterly report | View Diff | Apr 23, 2025 | |
| ARS | Annual report to shareholders | Mar 12, 2025 | ||
| 10-K | Annual report | View Diff | Feb 13, 2025 | |
| 10-Q | Quarterly report | View Diff | Oct 23, 2024 |
Events
| 8-K | Johnson Johnsons Executive Vice President Jennifer Taubert to Retire Tom Cavanaugh Appointed Evp, Worldwide Chairman Innovative Medicine Effective September | Aug 4, 2026 | ||
| 8-K | Johnson Johnson Completes Acquisition of Firefly Bio, Inc. to Advance Next-Generation Oncology Innovation | Jul 29, 2026 | ||
| 8-K | For Release at 615pm Et | Jul 27, 2026 | ||
| 8-K | Johnson Johnson Reports Q2 2026 Results, Raises 2026 Outlook | Jul 15, 2026 | ||
| 8-K | Submission of Matters to a Vote of Security Holders | Apr 27, 2026 | ||
| 8-K | Johnson & Johnson Reports Q1 2026 Results, Raises 2026 Outlook | Apr 14, 2026 | ||
| 8-K | Johnson & Johnson Reports Q4 and Full-Year 2025 Results | Jan 21, 2026 | ||
| 8-K | Johnson & Johnson Reports Q3 2025 Results; Raises 2025 Sales Outlook | Oct 14, 2025 | ||
| 8-K | Departure of Directors or Certain Officers | Sep 8, 2025 | ||
| 8-K | Johnson & Johnson Reports Q2 2025 Results; Raises 2025 Outlook | Jul 16, 2025 |
Registrations and Prospectuses
| S-3ASR | Automatic shelf registration | Feb 11, 2026 | ||
| 8-A12B | Registration of securities on exchange | Feb 26, 2025 | ||
| 424B2 | Prospectus for primary offering | Feb 21, 2025 | ||
| 424B2 | Prospectus for primary offering | Feb 19, 2025 | ||
| FWP | Free writing prospectus | Feb 19, 2025 | ||
| 424B5 | Prospectus supplement for primary offering | Feb 19, 2025 | ||
| FWP | Free writing prospectus | Feb 18, 2025 | ||
| 424B5 | Prospectus supplement for primary offering | Feb 18, 2025 | ||
| 25-NSE | Exchange delisting | Nov 6, 2024 | ||
| 8-A12B | Registration of securities on exchange | May 20, 2024 |
Proxies
| N-PX | Annual report of proxy voting record | Aug 10, 2026 | ||
| DEFA14A | Proxy Filing | Mar 11, 2026 | ||
| DEF 14A | Annual Meeting of Shareholders | View Diff | Mar 11, 2026 | |
| N-PX | Annual report of proxy voting record | Aug 26, 2025 | ||
| PX14A6G | Letter to shareholders | Apr 23, 2025 | ||
| PX14A6G | Letter to shareholders | Mar 20, 2025 | ||
| DEFA14A | Additional proxy soliciting materials | Mar 12, 2025 | ||
| DEF 14A | Definitive proxy | View Diff | Mar 12, 2025 | |
| DFAN14A | Additional proxy materials by non-management | Mar 7, 2025 | ||
| DFAN14A | Annual Meeting of Shareholders | Feb 25, 2025 |
Other
| SD | Conflict minerals disclosure | May 27, 2026 | ||
| SD | Conflict minerals disclosure | May 28, 2025 | ||
| UPLOAD | Letter from SEC | May 2, 2025 | ||
| CORRESP | Correspondence with SEC | Apr 23, 2025 | ||
| UPLOAD | Letter from SEC | Apr 16, 2025 | ||
| CERT | Certification of approval for exchange listing | Feb 28, 2025 | ||
| SD | Conflict minerals disclosure | May 28, 2024 | ||
| CERT | Certification of approval for exchange listing | May 21, 2024 | ||
| SD | Conflict minerals disclosure | May 24, 2023 | ||
| SD | Conflict minerals disclosure | May 26, 2022 |
Ownership
| 4 | Pinto Daniel E | Sep 10, 2026 | ||
| 4 | Woods Eugene A. | Sep 10, 2026 | ||
| 4 | Hewson Marillyn A | Sep 10, 2026 | ||
| 4 | Schmid Timothy | Sep 4, 2026 | ||
| 144 | Notice of proposed sale of securities | Sep 2, 2026 | ||
| 3 | Cavanaugh Thomas | Sep 1, 2026 | ||
| 4 | Taubert Jennifer L | Aug 18, 2026 | ||
| 144 | Notice of proposed sale of securities | Aug 17, 2026 | ||
| 4 | Duato Joaquin | Aug 14, 2026 | ||
| 144 | Notice of proposed sale of securities | Aug 13, 2026 |